144 related articles for article (PubMed ID: 16149296)
1. Hair growth after gefitinib treatment.
Lee LW; Burt PA
Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):492-3. PubMed ID: 16149296
[No Abstract] [Full Text] [Related]
2. Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.
Forde P; Murphy C; O'Sullivan C; Carney D
Ir J Med Sci; 2011 Mar; 180(1):283-4. PubMed ID: 20108129
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the epidermal growth factor receptor tyrosine kinase may predict response to gefitinib in non-small-cell lung cancer.
Clin Lung Cancer; 2004 May; 5(6):331-2. PubMed ID: 15217530
[No Abstract] [Full Text] [Related]
4. Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?
Stinchcombe TE; Ramalingam SS
Lancet Oncol; 2010 Jun; 11(6):500-1. PubMed ID: 20493770
[No Abstract] [Full Text] [Related]
5. Medical treatment of non-small-cell lung cancer.
Buter J; Giaccone G
Ann Oncol; 2005; 16 Suppl 2():ii229-32. PubMed ID: 15958463
[No Abstract] [Full Text] [Related]
6. Clinical development of gefitinib in non-small-cell lung cancer and the Iressa Survival Evaluation in Lung Cancer trial.
Price N; Belani C
Clin Lung Cancer; 2005 Jan; 6(4):214-6. PubMed ID: 15694012
[No Abstract] [Full Text] [Related]
7. [Development of individualized therapy of non-small cell lung cancer targeted at the EGF receptor].
Kakiuchi S; Yano S; Sone S
Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1831-8. PubMed ID: 16223143
[No Abstract] [Full Text] [Related]
8. Successful Treatment with Gefitinib in Advanced Non-Small Cell Lung Cancer after Acquired Resistance to Osimertinib.
Chic N; Mayo-de-Las-Casas C; Reguart N
J Thorac Oncol; 2017 Jun; 12(6):e78-e80. PubMed ID: 28532569
[No Abstract] [Full Text] [Related]
9. Gefitinib in lung cancer therapy: clinical results, predictive markers of response and future perspectives.
Adamo V; Franchina T; Adamo B; Denaro N; Gambadauro P; Chiofalo G; Scimone A; Caristi N; Russo A; Giordano A
Cancer Biol Ther; 2009 Feb; 8(3):206-12. PubMed ID: 19182534
[TBL] [Abstract][Full Text] [Related]
10. Updated data from the Iressa survival in lung cancer trial.
Tyagi P
Clin Lung Cancer; 2005 May; 6(6):340-2. PubMed ID: 15943893
[No Abstract] [Full Text] [Related]
11. The miracle of Iressa.
Chabner BA
Oncologist; 2004; 9(3):245-6. PubMed ID: 15169979
[No Abstract] [Full Text] [Related]
12. Gefitinib for non-small cell lung cancer patients with liver cirrhosis.
Kim YH; Mio T; Mishima M
Intern Med; 2009; 48(18):1677-9. PubMed ID: 19755773
[TBL] [Abstract][Full Text] [Related]
13. ZD1839 (Iressa) in non-small cell lung cancer.
Herbst RS; Kies MS
Oncologist; 2002; 7 Suppl 4():9-15. PubMed ID: 12202783
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib as a first line of therapy in non-small cell lung cancer with brain metastases.
Ishida A; Kanoh K; Nishisaka T; Miyazu Y; Iwamoto Y; Kohno N; Miyazawa T
Intern Med; 2004 Aug; 43(8):718-20. PubMed ID: 15468973
[TBL] [Abstract][Full Text] [Related]
15. Gefitinib (Iressa, ZD 1839) for non-small cell lung cancer (NSCLC): recents results and further strategies.
Manegold C
Adv Exp Med Biol; 2003; 532():247-52. PubMed ID: 12908563
[TBL] [Abstract][Full Text] [Related]
16. A case of residual non-small cell lung cancer cells coexisting with newly developed small cell lung cancer cells in ascitic fluid after chemotherapy for non-small cell lung cancer.
Park SH; Chi HS; Kim YJ; Cho YU; Jang S; Park CJ; Kim SW
Ann Lab Med; 2014 Mar; 34(2):163-5. PubMed ID: 24624356
[No Abstract] [Full Text] [Related]
17. Emerging role of erlotinib (OSI-774) in non-small-cell lung cancer.
Belani CP
Clin Lung Cancer; 2004 Dec; 6 Suppl 1():S6. PubMed ID: 15638958
[No Abstract] [Full Text] [Related]
18. [Not Available].
López-Brea M
Med Clin (Barc); 2016 Apr; 146 Suppl 1():1. PubMed ID: 27426240
[No Abstract] [Full Text] [Related]
19. [Molecular targeted therapies and cytotoxics: Friends or foes?].
Vignot S; Zalcman G
Bull Cancer; 2015 Jun; 102(6 Suppl 1):S91-2. PubMed ID: 26118883
[No Abstract] [Full Text] [Related]
20. Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Razis E; Skarlos D; Briasoulis E; Dimopoulos M; Fountzilas G; Lambropoulos S; Rigatos S; Kopterides P; Efstathiou H; Tzamakou E; Bakoyannis C; Pectasides D; Makatsoris T; Varthalitis G; Papadopoulos S; Kosmidis P
Anticancer Drugs; 2005 Feb; 16(2):191-8. PubMed ID: 15655417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
